sanjay gupta marijuana

Dr. Sanjay Gupta's recent op-ed that described his "doubling down" on support for medical marijuana has inspired a Colorado
"I am more convinced than ever that it is irresponsible to not provide the best care we can, care that often may involve
Dr. Sanjay Gupta recently explained the best ways to consume medical marijuana in an interview with Business Insider. Vaporizing
Sanjay Gupta has just been given the marijuana equivalent of a knighthood in the pot community -- he's had a strain of cannabis
President Barack Obama does not support changes to the legal classification of marijuana, the White House said Wednesday, despite growing evidence of its medical benefits. White House spokesman Josh Earnest was asked for the second day in a row if CNN chief medical correspondent Sanjay Gupta's recent reversal on medical marijuana use and apology for misleading the public had had any bearing on Obama's position on the issue.
WASHINGTON -- President Barack Obama does not support changes to the legal classification of marijuana, the White House said
Dennis also asked if Obama had personally been looking at the issue, given that national polls show rising support for marijuana
A remarkable documentary aired on Sunday night on marijuana, not necessarily for its conclusions, but for where it ran: CNN
It's no mistake that Dr. Gupta, a neurosurgeon by profession and one-time candidate for U.S. Surgeon General, has radically changed his position on medical cannabis.
Watch it all in the clip above. Visit NBCNews.com for breaking news, world news, and news about the economy All were topics
Dr. Sanjay Gupta is making waves for his recent reversal of opinion on medical marijuana. Part of this has to do with an expansive body of medical evidence but the touching story of a 5-year-old girl may have also played a meaningful role.
Gupta recently revealed that he has reversed his opposition to pot. In an interview with Piers Morgan, he apologized for
Gupta's dramatic intervention could prove influential in the ongoing debate about American drug policy; he is considered